最新公告:

  没有公告

您现在的位置: 心灵之窗-眼科医生网 >> 眼科常识 >> 第11届全国会 >> 青光眼11 >> 正文
专题栏目
更多内容
相关文章
更多内容
Trabeculectomy with Biodegradable 3D-Porous Collagen-glycosaminoglycan Scaffold for Treatment of Refractory Glaucoma         
Trabeculectomy with Biodegradable 3D-Porous Collagen-glycosaminoglycan Scaffold for Treatment of Refractory Glaucoma
作者:Henry Sh… 文章来源:Department of Ophthalmology, Chang Gung Memorial Hospital, Taipei 点击数:991 更新时间:2006/7/4 10:19:03
Purpose: Based on experience learned from earlier animal study, we describe a short-term pilot study that evaluates the safety and efficacy of trabeculectomy with implantation of OculusGen in refractory glaucoma patients. OculusGen, by its characteristics, improves the regenerating tissue-remodeling and reduces scar formation by guiding fibroblast to grow through the matrix pores randomly. Methods: In this multi-center, prospective and non-randomized study, 59 patients underwent trabeculectomy with new device in one eye for refractory glaucoma, which is defined as having previously failed medical, laser or surgical treatment, or some combination thereof. The OculusGen was implanted on the top of the scleral flap at the limbus before closing the conjunctival wound during trabeculectomy operations. Intraocular pressure (IOP), number of medications and complication were assessed before and after surgery. Results: The mean preoperative IOP was 38.67±7.45mmHg with 2.07±0.84 anti-glaucoma medications. Postoperatively, the mean IOP at last follow up (6 months) for all eyes was 16.11±3.17mmHg (58.3% reduction) with 0.33±0.18 anti-glaucoma medications. There were no significant intra-operative complications in any patients. Post-operative complications including transient shallow anterior chamber, hyphema and hypotony. Conclusions: The preliminary results of this study indicate that the OculusGen implantation in trabeculectomy represents a new, safe, simple and effective therapeutic approach for treating refractory glaucoma. Normalization of subconjunctival wound healing by tissue engineering is applied to traditional filtering surgery, bringing a novel approach to anti-scarring. A larger-scale and comparative study with a longer follow-up period is required to confirm these observation.
会议投稿录入:毛进    责任编辑:毛进 
  • 上一篇会议投稿:

  • 下一篇会议投稿:
  • 【字体: 】【发表评论】【加入收藏】【告诉好友】【打印此文】【关闭窗口
      网友评论:(只显示最新10条。评论内容只代表网友观点,与本站立场无关!)

    | 设为首页 | 加入收藏 | 联系站长 | 友情链接 | 版权申明 |
    眼科医生网 眼科医生网版权所有 @ 1998-2012
    部分文章和资源来源于网络,如果侵犯了您的版权,请指出! 站长:毛进
    信息产业部备案
    *京ICP备18030162号